Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Summary of Basic and Diluted Net Loss Per Share Computation

The following is a summary of the basic and diluted net loss per share computation for the periods presented and has been retroactively adjusted to reflect the Stock Dividends (see Note 1 — Organization for additional details):

	Three Months Ended March 31,
	2022		2021
Net loss attributable to common stockholders (in thousands)	$	(26,801)	$	(12,230)
Basic and diluted weighted-average shares outstanding (1)	102,000,624		101,930,013
Basic and diluted net loss per share (1)	$	(0.26)	$	(0.12)

(1) Retroactively adjusted for the effects of the Stock Dividends (see Note 1 — Organization for additional details).

Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company had the following common stock equivalents on a weighted-average basis that were excluded from the calculation of diluted net loss per share attributable to stockholders as their effect would have been antidilutive. The amounts in the table below have been retroactively adjusted to reflect the Stock Dividends (see Note 1 — Organization for additional details):

	Three Months Ended March 31,
	2022	2021
Unvested restricted shares (1)	164,047	234,640
Common OP Units (2)	448,287	448,287
Class B Units (3)	396,669	396,669
Total weighted average antidilutive common stock equivalents	1,009,003	1,079,596

________

(1) Weighted average number of antidilutive unvested restricted shares outstanding for the periods presented. There were 161,754 and 218,290 unvested restricted shares outstanding as of March 31, 2022 and 2021, respectively.

(2) Weighted average number of antidilutive Common OP Units presented as shares outstanding for the periods presented, at the current redemption rate reflecting adjustments for the effect of the Stock Dividends. There were 405,998 Common OP Units outstanding as of March 31, 2022 and 2021. The securities held by the Company are eliminated in consolidation.

(3) Weighted average number of antidilutive Class B Units presented as shares outstanding for the periods presented, at the current redemption rate reflecting adjustments for the effect of the Stock Dividends. There were 359,250 Class B Units outstanding as of March 31, 2022 and 2021. These Class B Units are unvested as of March 31, 2022 and 2021 (see Note 9 — Related Party Transactions for additional information).